Safety and pharmacokinetics of vitamin A therapy for infants with respiratory syncytial virus infections.
AUTOR(ES)
Neuzil, K M
RESUMO
Infants with respiratory syncytial virus infection have low serum vitamin A levels. We treated 21 respiratory syncytial virus-infected children with 12,500 to 25,000 IU of oral vitamin A. Vitamin A levels were normalized at 6 h, and none of the children experienced vitamin A toxicity or exacerbation of respiratory illness. Vitamin A treatment of previously healthy respiratory syncytial virus-infected infants at these doses is safe and well tolerated.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=162709Documentos Relacionados
- Detection, pathogenesis, and therapy of respiratory syncytial virus infections.
- Exposure of health care workers to ribavirin during therapy for respiratory syncytial virus infections.
- Respiratory syncytial virus, infants and intensive therapy
- Practical recommendations for the detection of pediatric respiratory syncytial virus infections.
- Environmental exposure of primary care personnel to ribavirin aerosol when supervising treatment of infants with respiratory syncytial virus infections.
